Celecoxib Versus Diclofenac In The Treatment Of Osteoarthritis Of The Hip
NCT ID: NCT00174317
Last Updated: 2006-12-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
250 participants
INTERVENTIONAL
2003-08-31
2005-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Celecoxib
Diclofenac
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Eligible for chronic therapy with an NSAID
Exclusion Criteria
* Active gastrointestinal disease or recent diagnosis of gastrointestinal ulceration (within 60 days of first visit)
45 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pfizer
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pfizer CT.gov Call Center
Role: STUDY_DIRECTOR
Pfizer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pfizer Investigational Site
Aston Clinton, Bucks, United Kingdom
Pfizer Investigational Site
Ely, Cambs, United Kingdom
Pfizer Investigational Site
St Austell, Cornwall, United Kingdom
Pfizer Investigational Site
Lancaster, England, United Kingdom
Pfizer Investigational Site
Sheffield, England, United Kingdom
Pfizer Investigational Site
Newport, Gwent, United Kingdom
Pfizer Investigational Site
Chingford, London, United Kingdom
Pfizer Investigational Site
Harrow, MIDDLESEX, United Kingdom
Pfizer Investigational Site
Greenisland, Carrickfergus, Northern Ireland, United Kingdom
Pfizer Investigational Site
Oxford, Oxon, United Kingdom
Pfizer Investigational Site
Greenock, Renfrewshire, United Kingdom
Pfizer Investigational Site
Barry, South Glamorgan, United Kingdom
Pfizer Investigational Site
Barnsley, South Yorkshire, United Kingdom
Pfizer Investigational Site
Ashford, Surrey, United Kingdom
Pfizer Investigational Site
Newcastle upon Tyne, Tyne & Wear, United Kingdom
Pfizer Investigational Site
Trowbridge, Wiltshire, United Kingdom
Pfizer Investigational Site
Aberdeen, , United Kingdom
Pfizer Investigational Site
Amersham, , United Kingdom
Pfizer Investigational Site
Bath, , United Kingdom
Pfizer Investigational Site
Bath, , United Kingdom
Pfizer Investigational Site
Belfast, , United Kingdom
Pfizer Investigational Site
Bradford, , United Kingdom
Pfizer Investigational Site
Cardiff, , United Kingdom
Pfizer Investigational Site
Carshalton, , United Kingdom
Pfizer Investigational Site
Chertsey, , United Kingdom
Pfizer Investigational Site
Edinburgh, , United Kingdom
Pfizer Investigational Site
Glasgow, , United Kingdom
Pfizer Investigational Site
Lancaster, , United Kingdom
Pfizer Investigational Site
Leystonstone, London, , United Kingdom
Pfizer Investigational Site
Liverpool, , United Kingdom
Pfizer Investigational Site
Liverpool, , United Kingdom
Pfizer Investigational Site
London, , United Kingdom
Pfizer Investigational Site
Manchester, , United Kingdom
Pfizer Investigational Site
Northampton, , United Kingdom
Pfizer Investigational Site
Norwich, , United Kingdom
Pfizer Investigational Site
Nuneaton, , United Kingdom
Pfizer Investigational Site
Peterborough, , United Kingdom
Pfizer Investigational Site
Sheffield, , United Kingdom
Pfizer Investigational Site
Southampton, , United Kingdom
Pfizer Investigational Site
Truro, , United Kingdom
Pfizer Investigational Site
Wansford, , United Kingdom
Pfizer Investigational Site
Watford, , United Kingdom
Pfizer Investigational Site
Westbury, , United Kingdom
Pfizer Investigational Site
Wigan, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
COXA-0508-261
Identifier Type: -
Identifier Source: org_study_id